Cargando…
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project
INTRODUCTION: Ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam and ceftolozane-tazobactam are novel antibiotics used to treat infections caused by multidrug-resistant pathogens (MDR). Their use should be supervised and monitored as part of an antimicrobial stewardship programme (ASP). Appr...
Autores principales: | Palacios-Baena, Zaira R, Valiente de Santis, Lucia, Maldonado, Natalia, Rosso-Fernández, Clara M, Borreguero, Irene, Herrero-Rodríguez, Carmen, López-Cárdenas, Salvador, Martínez-Marcos, Franciso J, Martín-Aspas, Andrés, Jiménez-Aguilar, Patricia, Castón, Juan J, Anguita-Santos, Francisco, Ojeda-Burgos, Guillermo, Aznarte-Padial, M Pilar, Praena-Segovia, Julia, Corzo-Delgado, Juan E, Esteban-Moreno, M Ángeles, Rodríguez-Baño, Jesús, Retamar, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398103/ https://www.ncbi.nlm.nih.gov/pubmed/32737088 http://dx.doi.org/10.1136/bmjopen-2019-035460 |
Ejemplares similares
-
Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study
por: Jiménez-Jorge, Silvia, et al.
Publicado: (2019) -
Longitudinal impact of interprofessional education on attitudes, skills and career trajectories: a protocol for a quasiexperimental study in New Zealand
por: Darlow, Ben, et al.
Publicado: (2018) -
Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study
por: Evans, Bridie Angela, et al.
Publicado: (2022) -
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021) -
Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol
por: Maldonado, Natalia, et al.
Publicado: (2023)